Mueller Karin Anne Lydia, Mueller Iris I, Weig Hans-Joerg, Doernberger Volker, Gawaz Meinrad
Kardiologie, Medizinische Klinik, Universitaetsklinikum Tuebingen, Tuebingen, Germany.
BMJ Case Rep. 2012 Jun 14;2012:bcr0920114855. doi: 10.1136/bcr.09.2011.4855.
CD endocarditis is a potentially lethal complication after implantation of permanent pacemakers or implantable cardioverter-defibrillators. Complete extraction of the hardware along with antibiotic treatment is the standard therapy. However, there is no standard procedure in the treatment of lead-associated infective endocarditis with large thrombotic vegetations. The authors present the case of a 60-year-old patient with a large vegetation located on the right atrial lead. Due to a high surgical and thrombembolic risk, especially of acute massive pulmonary embolism, the patient received recombinant tissue plasminogen activator to dissolve the thrombus under echocardiographic monitoring. The thrombotic masses were substantially reduced after thrombolysis. Therefore, standard transvenous extraction of the leads could be performed and high risk cardiac re-operation could be avoided.
心脏装置相关感染性心内膜炎(CD endocarditis)是永久性起搏器或植入式心脏复律除颤器植入术后一种潜在致命的并发症。取出硬件装置并进行抗生素治疗是标准疗法。然而,对于伴有大的血栓性赘生物的导线相关感染性心内膜炎,目前尚无标准治疗程序。作者报告了一例60岁患者,其右心房导线处有一个大的赘生物。由于手术和血栓栓塞风险高,尤其是急性大面积肺栓塞风险,该患者在超声心动图监测下接受了重组组织型纤溶酶原激活剂溶栓治疗。溶栓后血栓性团块明显缩小。因此,可以进行标准的经静脉导线取出术,避免了高风险的心脏再次手术。